WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM
Report
- Report Number
- 2134265-2022-03068
- Event Type
- Injury
- Date Received
- March 18, 2022
- Date of Event
- March 1, 2022
- Report Date
- March 29, 2022
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NGV
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IA, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CORRECTION: H6: PATIENT CODE HAS BEEN UPDATED FROM CVA TO NO CLINICAL SIGNS, SYMPTOMS, OR CONDITIONS AND THIS EVENT IS NO LONGER A COMPLAINT.
OPTION STUDY. IT WAS REPORTED THAT A CEREBRAL VASCULAR ACCIDENT OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS SUCCESSFULLY PERFORMED USING A 27 MM WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). POST PROCEDURE, ASPIRIN WAS STARTED AND APIXABAN WAS CONTINUED. ON (B)(6) 2019, THE PATIENT WAS DISCHARGED. ON (B)(6) 2022, 867 DAYS POST INDEX PROCEDURE, THE PATIENT WAS HOSPITALIZED FOR A CEREBRAL VASCULAR ACCIDENT (CVA). THE PATIENT WAS TAKING APIXABAN AT THE TIME OF THE EVENT. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.
OPTION STUDY. IT WAS REPORTED THAT A CEREBRAL VASCULAR ACCIDENT OCCURRED. A LEFT ATRIAL APPENDAGE (LAA) CLOSURE PROCEDURE WAS SUCCESSFULLY PERFORMED USING A 27 MM WATCHMAN FLX LAA CLOSURE DEVICE WITH DELIVERY SYSTEM (WDS). POST PROCEDURE, ASPIRIN WAS STARTED AND APIXABAN WAS CONTINUED. ON (B)(6) 2019, THE PATIENT WAS DISCHARGED. ON (B)(6) 2022, 867 DAYS POST INDEX PROCEDURE, THE PATIENT WAS HOSPITALIZED FOR A CEREBRAL VASCULAR ACCIDENT (CVA). THE PATIENT WAS TAKING APIXABAN AT THE TIME OF THE EVENT. NO FURTHER INFORMATION IS CURRENTLY AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 15473 | WATCHMAN FLX LEFT ATRIAL APPENDAGE CLOSURE DEVICE WITH DELIVERY SYSTEM | SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL | NGV | BOSTON SCIENTIFIC CORPORATION | 10393 | 0022800010 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | Male | Other |